Cadrenal Therapeutics, Inc. (CVKD) has 3 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $96K. Most recent filing: July 1, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 1, 2026 filed June 29, 2026 | Pham Quang X Chairman and CEO | −$22,422 | 7,400 | −7% | Yes | |
|
|
||||||
| June 26, 2026 filed June 25, 2026 | Pham Quang X Chairman, CEO and Interim CFO | −$33,919 | 11,156 | −10% | Yes | |
|
|
||||||
| June 24, 2026 filed June 22, 2026 | Pham Quang X Chairman, CEO and Interim CFO | −$39,829 | 11,444 | −9% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free